Pavan Kumar Togapur

Title: Innovations of Pavan Kumar Togapur

Introduction

Pavan Kumar Togapur is a notable inventor based in Telangana, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds with therapeutic potential. His work has led to the filing of multiple patents, showcasing his innovative approach to solving complex scientific problems.

Latest Patents

Pavan Kumar Togapur holds 2 patents that highlight his expertise in the development of selective HDAC inhibitors. One of his latest patents involves the creation of indole (sulfomyl) n-hydroxy benzamide derivatives, which serve as selective HDAC inhibitors. These compounds are characterized by a general formula where Ring A and B can be aryl, heteroaryl, cycloalkyl, or fused groups, with various substituents such as hydrogen, alkoxy, and halogen. The second patent focuses on a process for the preparation of Zafirlukast and its analogs, utilizing a protection group-free strategy and C—H bond activation. This innovative process includes steps such as Sonogashira coupling and reductive hydrogenation.

Career Highlights

Pavan Kumar Togapur is affiliated with the Council of Scientific & Industrial Research, where he conducts research and development in the field of pharmaceuticals. His work is characterized by a commitment to advancing medicinal chemistry and improving therapeutic options for various diseases.

Collaborations

He has collaborated with notable colleagues, including Chandrasekhar Srivari and Prathama Satyendra Mainkar, to further enhance the impact of his research and innovations.

Conclusion

Pavan Kumar Togapur's contributions to the field of medicinal chemistry through his patents and collaborative efforts demonstrate his dedication to innovation and scientific advancement. His work continues to pave the way for new therapeutic developments.